Resources

Type of publications
Regions
Diseases

5255 results found

2021 ∙ Zeynali Bujani, M. Behnampour, M. Rahimi, N. Safari, T. Khazaei Feizabad, A. Hossein Sarbazi, A. Baniasadi, M. Rezaei, N. Ansari Moghaddam, A.

The effect of influenza vaccination on covid-19 morbidity, severity and mortality: Systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Nielsen, K. J. Jakobsen, K. K. Jensen, J. S. Gronhoj, C. Von Buchwald, C.

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection-A Systematic Review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Ho, T. C. Chen, Y. M. A. Chan, H. P. Chang, C. C. Chuang, K. P. Lee, C. H. Yuan, C. H. Tyan, Y. C. Yang, M. H.

The effects of heterologous immunization with prime‐boost covid‐19 vaccination against sars‐cov‐2

  • Adults
  • Older adults
  • Safety
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zhang, J. Qin, Z. Lou, C. Huang, J. Xiong, Y.

The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis

  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Shan, J. Britton, P. N. King, C. L. Booy, R.

The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review

  • Newborn
  • Children
  • Pregnant women
  • Adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Wang, J. Tong, Y. Li, D. Li, J. Li, Y.

The Impact of Age Difference on the Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Motaze, N. V. Mthombothi, Z. E. Adetokunboh, O. Hazelbag, C. M. Saldarriaga, E. M. Mbuagbaw, L. Shey Wiysonge, C.

The impact of rubella vaccine introduction on rubella infection and congenital rubella syndrome: A systematic review of mathematical modelling studies

  • All age groups
  • Rubella
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Lassi, Z. S. Naseem, R. Salam, R. A. Siddiqui, F. Das, J. K.

The impact of the COVID-19 pandemic on immunization campaigns and programs: A systematic review

  • All age groups
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Hasan, T. Beardsley, J. Marais, B. J. Nguyen, T. A. Fox, G. J.

The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines

  • All age groups
  • Healthcare workers
  • COVID-19
  • Coverage
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Okoli, G. N. Al-Yousif, Y. Reddy, V. K. Lê, M. L. Neilson, C. J. Abou-Setta, A. M.

The Number Needed to Vaccinate (NNV) against herpes zoster: a systematic review with meta-analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...